256 related articles for article (PubMed ID: 29546479)
1. Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.
Dettmar L; Ahmed N; Kotzsch M; Diersch S; Napieralski R; Darmoul D; Schmitt M; Weichert W; Kiechle M; Dorn J; Magdolen V
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1109-1118. PubMed ID: 29546479
[TBL] [Abstract][Full Text] [Related]
2. Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
Gong W; Liu Y; Seidl C; Dreyer T; Drecoll E; Kotzsch M; Bronger H; Dorn J; Magdolen V
PLoS One; 2019; 14(2):e0212968. PubMed ID: 30811511
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.
Geng X; Liu Y; Diersch S; Kotzsch M; Grill S; Weichert W; Kiechle M; Magdolen V; Dorn J
PLoS One; 2017; 12(11):e0186847. PubMed ID: 29095848
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Seidl C; Diamandis EP; Kiechle M; Drecoll E; Kotzsch M; Magdolen V; Dorn J
BMC Cancer; 2019 Jul; 19(1):696. PubMed ID: 31307411
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S
Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.
Ahmed N; Dorn J; Napieralski R; Drecoll E; Kotzsch M; Goettig P; Zein E; Avril S; Kiechle M; Diamandis EP; Schmitt M; Magdolen V
Biol Chem; 2016 Dec; 397(12):1265-1276. PubMed ID: 27483364
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
[TBL] [Abstract][Full Text] [Related]
9. Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.
Tokas T; Avgeris M; Alamanis C; Scorilas A; Stravodimos KG; Constantinides CA
J Cancer Res Clin Oncol; 2017 Mar; 143(3):521-532. PubMed ID: 27858162
[TBL] [Abstract][Full Text] [Related]
10. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
[TBL] [Abstract][Full Text] [Related]
11. HSP60 predicts survival in advanced serous ovarian cancer.
Hjerpe E; Egyhazi S; Carlson J; Stolt MF; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
Int J Gynecol Cancer; 2013 Mar; 23(3):448-55. PubMed ID: 23429486
[TBL] [Abstract][Full Text] [Related]
12. Plasmin(ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer.
Zhao S; Dorn J; Napieralski R; Walch A; Diersch S; Kotzsch M; Ahmed N; Hooper JD; Kiechle M; Schmitt M; Magdolen V
Biol Chem; 2017 Jun; 398(7):765-773. PubMed ID: 27935848
[TBL] [Abstract][Full Text] [Related]
13. Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung.
Planque C; Bléchet C; Ayadi-Kaddour A; Heuzé-Vourc'h N; Dumont P; Guyétant S; Diamandis EP; El Mezni F; Courty Y
Biol Chem; 2008 Jun; 389(6):781-6. PubMed ID: 18627302
[TBL] [Abstract][Full Text] [Related]
14. Low RAP80 mRNA expression correlates with shorter survival in sporadic high-grade serous ovarian carcinoma.
Romeo M; Karachaliou N; Chaid I; Queralt C; De Aguirre I; Del Carmen Gómez M; Sanchez-Ronco M; Radua J; Ramírez JL; Rosell R
Int J Biol Markers; 2017 Mar; 32(1):e90-e95. PubMed ID: 27443420
[TBL] [Abstract][Full Text] [Related]
15. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
Yousef GM; Borgoño CA; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris ME; Roagna R; Sismondi P; Diamandis EP
Br J Cancer; 2002 Nov; 87(11):1287-93. PubMed ID: 12439719
[TBL] [Abstract][Full Text] [Related]
17. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.
Gueugnon F; Barascu A; Mavridis K; Petit-Courty A; Marchand-Adam S; Gissot V; Scorilas A; Guyetant S; Courty Y
Tumour Biol; 2015 Jul; 36(7):4979-86. PubMed ID: 25677900
[TBL] [Abstract][Full Text] [Related]
19. Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.
Kim SI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
J Ovarian Res; 2019 May; 12(1):40. PubMed ID: 31064392
[TBL] [Abstract][Full Text] [Related]
20. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.
Yousef GM; Fracchioli S; Scorilas A; Borgoño CA; Iskander L; Puopolo M; Massobrio M; Diamandis EP; Katsaros D
Am J Clin Pathol; 2003 Mar; 119(3):346-55. PubMed ID: 12645335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
